#England

A sweeping survey of tens of thousands of women across England has found that about one in four report living with at least one serious reproductive health issue. The findings, drawn from responses collected in 2023 from roughly 60,000 participants, point to a broad burden of conditions ranging from heavy menstrual bleeding and chronic pelvic pain to infertility and menopause-related symptoms. The scale is described by researchers as the most comprehensive look yet at the prevalence and impact of reproductive health problems in England, and they emphasize that the numbers likely reflect not just medical diagnoses but also the social and economic barriers that push people away from timely care.

England has taken a pioneering step in global public health by launching the world’s first vaccination program targeting gonorrhoea, a sexually transmitted infection (STI) that has reached record highs and shows worrying resistance to antibiotics. Starting from August 2025, sexual health clinics across England are now offering the vaccine—adapted from the 4CMenB meningococcal B vaccine—to people at highest risk, marking a significant move in the fight against a disease that has challenged medical professionals for decades. Health officials, experts, and advocacy groups alike are hailing the effort as a critical intervention with relevance for countries confronting rising STI rates, including Thailand.